Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-08
DOI
10.1186/s13063-020-04516-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
- (2018) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- Antibody-Mediated Encephalitis
- (2018) Josep Dalmau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis
- (2017) Olafur Sveinsson et al. JOURNAL OF NEUROIMMUNOLOGY
- Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
- (2017) Josep Dalmau et al. PHYSIOLOGICAL REVIEWS
- Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study
- (2016) Josephine Heine et al. JOURNAL OF NEUROLOGY
- A clinical approach to diagnosis of autoimmune encephalitis
- (2016) Francesc Graus et al. LANCET NEUROLOGY
- Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
- (2016) Franziska Scheibe et al. NEUROLOGY
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
- (2015) Juan Jakez-Ocampo et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy
- (2012) O. Winter et al. JOURNAL OF IMMUNOLOGY
- Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
- (2011) E. Martinez-Hernandez et al. NEUROLOGY
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
- (2010) Sarosh R. Irani et al. BRAIN
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
- (2010) Josep Dalmau et al. LANCET NEUROLOGY
- Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin
- (2010) H. Pruss et al. NEUROLOGY
- A guide to the design and analysis of small clinical studies
- (2010) Farid Kianifard et al. PHARMACEUTICAL STATISTICS
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now